Central Trust Company’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29
| Closed | -$43 | – | 1433 |
|
|
2024
Q1 | $43 | Hold |
29
| – | – | ﹤0.01% | 1366 |
|
|
2023
Q4 | $32 | Hold |
29
| – | – | ﹤0.01% | 1376 |
|
|
2023
Q3 | $35 | Hold |
29
| – | – | ﹤0.01% | 1353 |
|
|
2023
Q2 | $41 | Hold |
29
| – | – | ﹤0.01% | 1226 |
|
|
2023
Q1 | $44 | Hold |
29
| – | – | ﹤0.01% | 1260 |
|
|
2022
Q4 | $34 | Hold |
29
| – | – | ﹤0.01% | 1243 |
|
|
2022
Q3 | $0 | Hold |
29
| – | – | ﹤0.01% | 1367 |
|
|
2022
Q2 | $0 | Hold |
29
| – | – | ﹤0.01% | 1415 |
|
|
2022
Q1 | $0 | Hold |
29
| – | – | ﹤0.01% | 1429 |
|
|
2021
Q4 | $0 | Hold |
29
| – | – | ﹤0.01% | 1309 |
|
|
2021
Q3 | $0 | Hold |
29
| – | – | ﹤0.01% | 1270 |
|
|
2021
Q2 | $0 | Hold |
29
| – | – | ﹤0.01% | 1224 |
|
|
2021
Q1 | $0 | Hold |
29
| – | – | ﹤0.01% | 1126 |
|
|
2020
Q4 | $0 | Hold |
29
| – | – | ﹤0.01% | 1088 |
|
|
2020
Q3 | $0 | Hold |
29
| – | – | ﹤0.01% | 1087 |
|
|
2020
Q2 | $0 | Hold |
29
| – | – | ﹤0.01% | 1109 |
|
|
2020
Q1 | $0 | Hold |
29
| – | – | ﹤0.01% | 1184 |
|
|
2019
Q4 | $0 | Hold |
29
| – | – | ﹤0.01% | 1195 |
|
|
2019
Q3 | $0 | Hold |
29
| – | – | ﹤0.01% | 1171 |
|
|
2019
Q2 | $0 | Hold |
29
| – | – | ﹤0.01% | 1159 |
|
|
2019
Q1 | $0 | Buy |
+29
| New | – | ﹤0.01% | 1126 |
|